Joy Gispati Ghosh

age ~46

from Boston, MA

Get Report

Also known as:

Joy G Ghosh
Gispati Ghosh

Connected to:

Joy Ghosh Phones & Addresses

Boston, MA
Brookline, MA
3801 Brooklyn Ave NE, Seattle, WA 98105
Danbury, CT
Irving, TX
Austin, TX
Fort Worth, TX
Arlington, TX
101 Monmouth St APT 408, Brookline, MA 02446

Us Patents

Compositions And Methods For Treatment Of Protein Misfolding And Protein Aggregation Diseases
view source
US Patent:

20080227700, Sep 18, 2008
Filed:

Nov 4, 2005
Appl. No.:

11/718708
Inventors:

Joy G. Ghosh - Seattle WA, US
John I Clark - Seattle WA, US
International Classification:

A61K 38/16
C07K 14/00
C07K 7/06
C07K 7/08
G01N 33/68
C12Q 1/02
G01N 33/53
A61K 38/10
A61K 38/08
US Classification:

514 12, 530328, 530327, 530326, 530325, 530324, 514 16, 514 15, 514 14, 514 13, 435 721, 436 86, 435 29
Abstract:

Small molecular weight molecules are provided including, but not limited to, peptides, peptide analogs and peptide mimetics that stabilize and prevent the aggregation of abnormally folded and compromised proteins. Methods for treatment of disease are provided utilizing the peptides, peptide analogs or peptide mimetics, or utilizing nucleic acids encoding the peptides.

Compositions And Methods For Treatment Of Cancer Or Neurodegenerative Disease With Peptide Based Microtubule Stabilizers Or Inhibitors
view source
US Patent:

20080280824, Nov 13, 2008
Filed:

May 7, 2007
Appl. No.:

11/745360
Inventors:

Joy G. Ghosh - Seattle WA, US
John I. Clark - Seattle WA, US
Scott Andrew Houck - Woodinville WA, US
Assignee:

University of Washington - Seattle WA
International Classification:

A61K 38/00
A61P 25/00
C12Q 1/02
US Classification:

514 12, 514 13, 514 15, 514 16, 514 17, 514 18, 514 19, 435 29
Abstract:

Small molecular weight molecules are provided including, but not limited to, peptides, peptide analogs and peptide mimetics that can interact with microtubules to promote their assembly or prevent their disassembly and can interrupt mitosis, prevent cell division, and trigger apoptosis. methods for the prevention or treatment of neoplastic disease in a mammalian subject are provided utilizing peptides, peptide analogs and peptide mimetics, or utilizing nucleic acids encoding the peptides.

Compositions And Methods For Antibodies Targeting Factor P
view source
US Patent:

20130295102, Nov 7, 2013
Filed:

Dec 17, 2012
Appl. No.:

13/716526
Inventors:

- Basel, CH
Ute Jaeger - Muenchen, DE
Yong-In Kim - Westborough MA, US
Christian Carsten Silvester Kunz - Muenchen, DE
Igor Splawski - Winchester MA, US
Michael Roguska - Ashland MA, US
Joy Ghosh - Brookline MA, US
Barbara Brannetti - Basel, CH
International Classification:

C07K 16/18
G01N 33/68
C07K 16/24
A61K 39/395
US Classification:

4241391, 5303879, 5303873, 536 2353, 4353201, 435330, 435375, 435 74
Abstract:

The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).

Compositions And Methods For Treatment Of Protein Misfolding And Protein Aggregation Diseases
view source
US Patent:

20070185028, Aug 9, 2007
Filed:

Dec 1, 2006
Appl. No.:

11/607519
Inventors:

Joy Ghosh - Seattle WA, US
John Clark - Seattle WA, US
International Classification:

A61K 38/16
A61K 38/10
A61K 38/08
C07K 7/08
C07K 14/47
US Classification:

514012000, 514013000, 514014000, 514015000, 514016000, 530324000, 530325000, 530326000, 530327000, 530328000, 530329000
Abstract:

Small molecular weight molecules are provided including, but not limited to, peptides, peptide analogs and peptide mimetics that stabilize and prevent the aggregation of abnormally folded and compromised proteins. Methods for treatment of disease are provided utilizing the peptides, peptide analogs or peptide mimetics, or utilizing nucleic acids encoding the peptides.

Anti-Betacellulin Antibodies, Fragments Thereof, And Multi-Specific Binding Molecules
view source
US Patent:

20220356236, Nov 10, 2022
Filed:

Jun 30, 2022
Appl. No.:

17/809941
Inventors:

- Basel, CH
Ana Maria CARRION - Wellesley MA, US
James Edgar CHASTAIN - Acton MA, US
Kirk Lee CLARK - Stow MA, US
Joy Gispati GHOSH - Boston MA, US
Shawn Michael HANKS - Sudbury MA, US
Nicole HAUBST - Munchen, DE
Ganesh Rajan IYER - South Grafton MA, US
Nina MOKER - Koln, DE
Andrew Anh NGUYEN - Brookline MA, US
Stephen Hendrick POOR - Winthrop MA, US
Yubin QIU - Newton MA, US
Nalini Velamur RANGASWAMY - Wakefield MA, US
Michael STEFANIDAKIS - Brookline MA, US
Engin TOKSOZ - Munchen, DE
Michael Zbigniew TWAROG - Cambridge MA, US
International Classification:

C07K 16/22
A61P 27/02
C07K 16/46
Abstract:

The present disclosure provides anti-BTC antibodies, methods of producing said antibodies, pharmaceutical compositions comprising said antibodies, and methods of using said antibodies. The present disclosure also provides multi-specific binding molecules, e.g., bispecific antibodies, comprising a BTC binding moiety and an anti-VEGF binding moiety.

Anti-Betacellulin Antibodies, Fragments Thereof, And Multi-Specific Binding Molecules
view source
US Patent:

20220348646, Nov 3, 2022
Filed:

Jun 30, 2022
Appl. No.:

17/809943
Inventors:

- Basel, CH
Ana Maria CARRION - Wellesley MA, US
James Edgar CHASTAIN - Acton MA, US
Kirk Lee CLARK - Stow MA, US
Joy Gispati GHOSH - Boston MA, US
Shawn Michael HANKS - Sudbury MA, US
Nicole HAUBST - , US
Ganesh Rajan IYER - South Grafton MA, US
Nina MOKER - , US
Andrew Anh NGUYEN - Brookline MA, US
Stephen Hendrick POOR - Winthrop MA, US
Yubin QIU - Newton MA, US
Nalini Velamur RANGASWAMY - Wakefield MA, US
Michael STEFANIDAKIS - Brookline MA, US
Engin TOKSOZ - , US
Michael Zbigniew TWAROG - Cambridge MA, US
International Classification:

C07K 16/22
A61P 27/02
C07K 16/46
Abstract:

The present disclosure provides anti-BTC antibodies, methods of producing said antibodies, pharmaceutical compositions comprising said antibodies, and methods of using said antibodies. The present disclosure also provides multi-specific binding molecules, e.g., bispecific antibodies, comprising a BTC binding moiety and an anti-VEGF binding moiety.

Compositions And Methods For Antibodies Targeting Factor P
view source
US Patent:

20180327486, Nov 15, 2018
Filed:

May 7, 2018
Appl. No.:

15/973225
Inventors:

- Basel, CH
Ute JAEGER - Muenchen, DE
Yong-In KIM - Seongnam-si, KR
Christian Carsten Silvester KUNZ - Muenchen, DE
Igor SPLAWSKI - Winchester MA, US
Michael ROGUSKA - Old Orchard Beach ME, US
Joy GHOSH - Boston MA, US
Barbara BRANNETTI - Cambridge MA, US
Michael STEFANIDAKIS - Brookline MA, US
Sha-Mei LIAO - Lexington MA, US
Assignee:

Novartis AG - Basel
International Classification:

C07K 16/18
C07K 16/24
G01N 33/68
A61K 39/395
Abstract:

The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).

Methods Of Treating Ophthalmic Disorders
view source
US Patent:

20180230540, Aug 16, 2018
Filed:

Aug 11, 2016
Appl. No.:

15/751787
Inventors:

Joy GHOSH - Boston MA, US
Yunsheng HE - Waltham MA, US
International Classification:

C12Q 1/6883
C07K 16/22
A61P 27/02
Abstract:

The invention features methods of identifying patients as being likely to respond to anti-VEGF therapy. Furthermore, in those patients identified as failing to include one or more of the above ophthalmic response markers, the invention features treatment with an EPO antagonist (e.g., alone, or in combination with a VEGF antagonist).

Resumes

Senior Research Analyst

view source

Location:

Seattle, WA

Industry:

Venture Capital & Private Equity

Work:

Bain Capital
Associate
Biogen May 2016 - Jan 2017
Senior Manager, Corporate Development, M and A, and Strategy
Novartis Institutes For Biomedical Research (Nibr) Sep 2013 - May 2016
Investigator Iii
Novartis Sep 2013 - May 2016
Team Member Â Business Development and Licensing Team
Novartis Institutes For Biomedical Research (Nibr) May 2009 - Sep 2013
Investigator Ii

Education:

Harvard Medical School May 2009
Cold Spring Harbor Laboratory 2007 - 2007
University of Washington 2006
University of Washington - Michael G. Foster School of Business 2004 - 2006
University of Washington - School of Medicine 2000 - 2006
Doctorates, Doctor of Philosophy, Biology, Neuroscience The Benaroya Research Institute 2005
University of Washington 2004
The University of Texas at Austin 1998 - 2000
Bachelors, Bachelor of Science, Biochemistry

Skills:

Drug Discovery
Drug Development
Molecular Biology
Life Sciences
Biochemistry
Assay Development
Biotechnology
Protein Chemistry
Cell Biology
Neuroscience
Business Development
Pharmaceutical Industry
Immunology
Antibodies
Lifesciences
Clinical Trials
Business Strategy
Cross Functional Team Leadership
Commercialization
Monoclonal Antibodies
Pharmacokinetics
Technology Transfer
Due Diligence
Oncology
Strategic Leadership
Translational Research
Financial Modeling
Drug Design
Translational Medicine
Entrepreneurship
Neurodegeneration
Program Management
Ophthalmology
Protein Engineering
Business Valuation
Diabetic Retinopathy
Alzheimer's Disease
Medicine
Protein Purification
Parkinson's
Diabetes
Ind
Biologics
Target Identification
Drug Delivery

Languages:

Hindi
French

Certifications:

Certificate In Entrepreneurship and Innovation

Joy Ghosh

view source

Joy Ghosh

view source

Joy Ghosh

view source

Location:

Greater Boston Area

Industry:

Pharmaceuticals

Skills:

Drug Discovery
Drug Design
Monoclonal Antibodies
Protein Engineering
Translational Research
Translational Medicine
Immunology
Ophthalmology
Macular Degeneration
Commercialization
Entrepreneurship
Diabetic Retinopathy
Alzheimer's disease
Neurodegeneration
Medicine
Antibodies
Lifesciences
Biophysics
Drug Development
Neuroscience
Assay Development
Biochemistry
Molecular Biology
Protein Chemistry
In Vitro
Fluorescence
Cell Biology
Protein Expression
Protein Purification
Validation
ELISA
Molecular Cloning
DNA
Bioinformatics
Parkinson's
Diabetes
Cancer

Languages:

Hindi